Peregrine Capital Management LLC Agios Pharmaceuticals, Inc. Transaction History

Peregrine Capital Management LLC

  • $3.18 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 19, 2021
SELL
$33.21 - $46.54 $5.46 Million - $7.65 Million
-164,315 Closed
0 $0
Q3 2020

Oct 20, 2020
SELL
$33.87 - $55.93 $530,234 - $875,584
-15,655 Reduced 8.7%
164,315 $5.75 Million
Q2 2020

Jul 30, 2020
BUY
$34.45 - $53.48 $6.2 Million - $9.62 Million
179,970 New
179,970 $9.62 Million

Others Institutions Holding AGIO

# of Institutions
232
Shares Held
58.1M
Call Options Held
403K
Put Options Held
469K
View Full List

About AGIOS PHARMACEUTICALS, INC.

AGIO Quotes by TradingView
  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email